A tyrosine kinase inhibitor is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation of many proteins by signal transduction cascades. From Wikipedia
Fresh phase 3 readouts at WCLC 2025 steer practice toward tailored combination regimens.
